Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting
NCT05633771 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 562
Last updated 2026-01-12
Summary
An international, multicenter, non-interventional, prospective, post-authorization, descriptive, non-PASS, study.
Conditions
Interventions
- OTHER
-
Hyrimoz
There is no treatment allocation. Patients administered Hyrimoz by prescription that have started as routine medical treatment will be enrolled.
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-16
- Primary Completion
- 2025-12-15
- Completion
- 2026-12-31
Countries
- Belgium
- France
Study Locations
More Related Trials
-
"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"
NCT02452151 ·Status: UNKNOWN ·Phase: PHASE4
-
A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy
NCT02177071 ·Status: COMPLETED ·Phase: PHASE4
-
Switching From Adalimumab to Infliximab
NCT01338740 ·Status: COMPLETED
-
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
NCT05181137 ·Status: UNKNOWN ·Phase: PHASE3
-
Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease
NCT03890445 ·Status: COMPLETED
-
A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05767021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases
NCT03370601 ·Status: TERMINATED ·Phase: NA
-
Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease
NCT02065570 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819878 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
NCT00409617 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
NCT00105300 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
NCT00524537 ·Status: COMPLETED
-
Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
NCT00195715 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
NCT02065622 ·Status: COMPLETED ·Phase: PHASE3
-
Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab
NCT02453776 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819891 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
NCT05394805 ·Status: COMPLETED
-
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
NCT02808780 ·Status: ACTIVE_NOT_RECRUITING
-
Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease
NCT02057016 ·Status: COMPLETED
-
Stop Infliximab in Patients With Crohn's Disease
NCT00571337 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients
NCT05927064 ·Status: COMPLETED
-
Efficacy Assessment and Monitoring of Subcutaneous Infliximab Levels.
NCT05071404 ·Status: COMPLETED
-
Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission
NCT03841942 ·Status: TERMINATED ·Phase: NA
-
Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis
NCT05486104 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)
NCT00705614 ·Status: COMPLETED